Stack
Analyzer
Choose the combination you use; See interaction & security auditing, function axis coverage and redundancy/gap notes on a single screen.
Substances in combination
Maximum 8 items. Your selection is saved in the link; you can share.
Interaction & security
- medium riskAcetyl-L-Carnitine
Asetil-L-Karnitin - dikkat
In breast cancer patients receiving taxane chemotherapy, ALCAR did not prevent neuropathy and was associated with worse neuropathy in a randomized trial; the adverse difference persisted in long follow-up. Do not self-use it to prevent chemotherapy neuropathy; consult the oncology team.
Combination profile
Functional axis coverage
Source distribution
Yarı-sentetik ×1
These results are screening warnings. Severity describes a potential concern, not its probability or the certainty of clinical evidence. Some rules extrapolate from mechanisms or drug classes; an absent warning does not establish safety.
Looking for a new combination? Start from a goal with the Nootropic Finder or browse the ready-made stacks.
FDA: Mixing Medications and Dietary Supplements Can Endanger Your Health